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biophysical characteristics that confer activity, we present here a molecular-dynamics and biophysical study of a cyclic antimi-
crobial peptide and its inactive linear analog. In the simulations, the cyclic peptide caused large perturbations in the bilayer and
cooperatively opened a disordered toroidal pore, 1–2 nm in diameter. Electrophysiology measurements confirm discrete pora-
tion events of comparable size. We also show that lysine residues aligning parallel to each other in the cyclic but not linear
peptide are crucial for function. By employing dual-color fluorescence burst analysis, we show that both peptides are able to
fuse/aggregate liposomes but only the cyclic peptide is able to porate them. The results provide detailed insight on the molecular
basis of activity of cyclic antimicrobial peptides.INTRODUCTIONHow antimicrobial peptides (AMPs) kill bacteria by inter-
acting with the cell membrane is not fully understood. These
peptides, often small and cationic, are secreted into the
aqueous phase, usually in an unfolded state and bind quickly
to the target membrane, where secondary structure may be
induced (1–8). At a certain threshold concentration, antimi-
crobial peptides permeabilize the membrane, either by
forming a discrete pore or by disrupting the bilayer structure
(2,4,6,9–19). For linear a-helical peptides, the barrel-stave
and toroidal-shaped model have been proposed as pore
structures (2,3,15,20–23). In addition, a disordered toroidal
pore has been proposed for linear antimicrobial peptides
from molecular-dynamics (MD) simulations (24–26).
Cyclic AMPs have emerged as good antimicrobial candi-
dates due to their robust secondary structure and high
activity (27–29). Gramicidin S, a cationic decapeptide, is
one of the best-studied cyclic AMPs (27,28,30–32) and
has been shown to permeabilize bilayers but not to stabilize
well-defined pores (33). MD simulations have shown that
cyclic peptides such as gramicidin S (34,35) and areni-
cin-2 (36) have b-structures with a relatively rigid back-
bone conformation. Arginine-rich cyclic peptides have
been shown to assemble into nanotubes and extrude the
bilayer in MD simulations (37). In general, the molecular
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. Open access under CC BY-NC-ND license.these short peptides can open and stabilize pores, as well
as the molecular basis for their increased activity, is still
unclear.
The focus of our work is a cyclic antimicrobial peptide,
BPC194, that was chosen as the best candidate from a library
of de novo synthesized cyclic peptides (38,39). The cyclic
peptide shows a high antimicrobial activity to different plant
pathogenic bacteria (Erwinia amylovora, Pseudomonas
syringae, and Xanthomonas vesicatoria). Here, we present
a combined MD and biophysical study of the cyclic peptide
interacting with anionic lipid bilayers to understand its
mechanism of action.
The linear analog BPC193, which is not active, has also
been studied, allowing us to reveal the functionally impor-
tant structural characteristics. We show that only the cyclic
peptide is able to form pores in anionic membranes in line
with its enhanced antimicrobial activity. The pore size was
validated by three independent approaches—MD simula-
tions, electrophysiology, dual-color fluorescence burst anal-
ysis (DCFBA), and fluorescence imaging. We further
extract the functionally relevant structural properties of
the peptides and show the importance of charged residues
in forming and stabilizing pores. Finally, an intermediate
state was identified which is close to the real transition state
during pore formation.MATERIALS AND METHODS
Molecular dynamics simulations
System setup
MD simulations were performed for systems containing nine peptides,
(BPC 194 c(KKLKKFKKLQ), BPC 193 H-KKLKKFKKLQ-OH), and
a fully solvated DPPG (dipalmitoyl-phosphatidylglycerol; anionic lipid)doi: 10.1016/j.bpj.2011.03.057
Action of Cyclic Antimicrobial Peptides 2423bilayer. The simulations were carried out at a peptide/lipid (P/L) of 9:128
for both cyclic and linear analogs together with 6000~8000 water molecules
and 128 Kþ as counterions for anionic lipids. The peptides were initially
placed in the water phase at a distance of 1.5–2.3 nm from the membrane
surface. The initial structure of the peptides was modeled using the
LEAP module of AMBER 9 (40), as unstructured peptides with no intramo-
lecular hydrogen bonds. Multiple simulations were run from different initial
random velocity distributions (see Table S1 in the Supporting Material).
Setup for transition state simulations
A snapshot at 109 ns was taken from the simulation 9Ca (Table S1) as an
example of the transition state. From this system, 10 simulations were
performed with different initial velocity distributions. The transition state
was also modified to substitute the cyclic peptide by the linear analog.
This substitution was made by cutting the peptide bond between
N-terminal residue and the C-terminal residue, as well as adding the cor-
responding missing atoms. The system was simulated as a linear peptide
but with the initial conformation of the cyclic peptide (the so-called hairpin
conformation). Further, a harmonic potential was applied to the linear
peptide to pull the N-terminal from C-terminal to obtain a random-coil
conformation in the transition state. For the modified systems, a minimiza-
tion was carried out followed by an equilibration with constraints on phos-
phorus atom and water molecules to keep the position of the transition
state. Ten simulations were run for the hairpin conformation and two of
the random-coil conformation by changing the starting random velocities
of a fully solvated DPPG bilayer.
Analysis
The secondary structure of the peptides was calculated by using the DSSP
code (41). For the cyclic peptide, the N-terminal residue K1 and C-terminal
residue Q10 that are present in the turn region were neglected while calcu-
lating the secondary structure. The structural properties were then calcu-
lated from the average number of residues involved in each secondary
structural feature along the simulation. The total b-structure is reported
as the sum of b-sheet and b-bridge and the total nonstructured as the sum
of coil, bend, and turn. The persistence of structure over timewas calculated
as the percentage of time the b-structure was present.
Simulation parameters
All MD simulations were performed with the GROMACS software package
(42). The peptide and peptide-solvent interactions were described by the
GROMOS force field 43a2 (43). The force field for DPPG lipids was opti-
mized from DPPC (44) and POPG (45) lipids, compatible with the
GROMOS96 parameters. The choline headgroups were replaced by glyc-
erol from the POPG force field, and the tail parameters were taken from
the DPPC force field. The parameters were then optimized to achieve an
area per lipid consistent with experiment (46).
The equilibrated DPPG bilayer had a thickness of 3.545 0.05 nm and an
area per lipid of 0.695 0.01 nm2. The force fields have been parameterized
for use with a group-based twin-range cutoff scheme (using cutoffs of
1.0/1.4 nm and a pair-list update frequency of once per 10 steps), including
a reaction field (47) correction with a dielectric constant of 78 to account for
the truncation of long-range electrostatic interactions. The water was
modeled using the SPC (simple-point charge) model (48).
The simulations were performed using periodic boundary conditions and
a time step of 2 fs was used. The temperature was weakly coupled (coupling
time 0.1 ps) to T ¼ 320 K, using the Berendsen thermostat (49). The pres-
sure was weakly coupled (coupling time of 1.0 ps and compressibility of
4.5  105), using a semiisotropic coupling scheme in which the lateral
(Pj) and perpendicular (PZ) pressures are coupled independently at 1 bar,
corresponding to a tension-free state of the membrane. The simulation setup
is similar to that used in previous studies of peptide-membrane interactions
(25,26,50). For a general review on MD studies of peptide-membrane inter-
actions, see Bond and Khalid (51) and Ma´tyus et al. (52).Biophysical characterization
Electrophysiology measurements
A planar lipid bilayer setup was used as described below. The bilayer was
formed by painting with 1 mL of a 20 mg/mL solution of 1,2-dioleoyl-sn-
glycero-3-phosphatidylglycerol lipid (DOPG; Avanti Polar Lipids,
Alabaster, AL) in n-decane (Sigma-Aldrich, St. Louis, MO) across the
250 mm opening of a Delrin cup that separates two solution-filled compart-
ments, designated cis and trans (53–55). Both compartments were filled
with a buffer solution consisting of 10 mM 2-(4-(2-hydroxyethyl)-1-piper-
azinyl)-ethanesulfonic acid (HEPES; Roche Diagnostics, Mannheim,
Germany), pH 7.0, containing 150 mM NaCl (Merck, Whitehouse Station,
NJ), further referred to as buffer A. The transmembrane current (Im) under
different applied potentials (V) was monitored, using an integrating Bilayer
Clamp Amplifier BC-535 (Warner Instruments, Harvard Apparatus,
Hamden, CT). Currents were filtered through an eight-pole low-pass Bessel
filter model No. LPF-8 (Warner Instruments) and digitized using Clampex
10.2 software (Axon Molecular Devices, Union City, CA).
Membrane conductance (Gm) events were identified as Gm ¼ Im/V and
analyzed with the Clampfit software (Axon Molecular Devices) (56). Only
membranes with capacitances between 80 and 120 pF were used, which
correspond to membrane diameters of 50–61 mm. Before adding the peptide,
the membranes were controlled for the lack of any leakage by applying the
same range of voltage as in the presence of peptide. The peptides at 3 and
10 mM were added to the cis side of the planar lipid bilayer and stirred for
1 min without applying voltage. In some cases a voltage of540 mV was
applied to preactivate the peptide and decrease the time needed to observe
activity. Subsequently, the conductance was recorded at different voltages
ranging from0 to550mV. Ten traces, total, were each recordedwith freshly
prepared DOPG membranes. The pore diameter was estimated by an
extended version of the model proposed by Hille (57,58) given by (59)
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where d is the diameter of the pore, r is the resistivity of the buffer, g is the
measured conductance, and l is the length of the pore. The unitary pore
conductance, g, was estimated from all recordings. The resistivity of the
buffer A was assumed to be 80 Um (58). The length of the pore equals
the membrane thickness and was assumed to be 3.5 nm.
Dual-color fluorescence burst analysis
In the DCFBA experiment, liposomes were labeled with two spectrally
nonoverlapping fluorescent probes (60). One probe was incorporated in
the phospholipid bilayer, whereas the other filled the aqueous interior of
the liposome. By using a dual-color laser-scanning microscope, we moni-
tored membrane-disrupting effects at the single liposome level. The results
are presented in the DCFBA profiles as the population-distribution histo-
gram of liposomes with a given internal marker concentration, Ci, given by
Ci ¼
R t2
t1
ISMdt R t2
t1
ILdt
3=2; (2)
where IL is the fluorescence of the lipid marker and ISM is the fluorescence
of the internal size marker in each fluorescence burst (61).
The average fluorophore population, Pfluorav , is given by
Pfluorav ¼
R t2
t1
Ifluor
Npeaks
dt
R t2
t1
I0fluor
N0peaks
dt
; (3)Biophysical Journal 100(10) 2422–2431
2424 Cirac et al.where Ifluor is the fluorescence intensity of each peak above a given
threshold for every P/L ratio; I 0fluor is Ifluor at P/L ¼ 0; Npeaks is the number
of peaks at every P/L; and N 0peaks is Npeaks at P/L ¼ 0. The relative popu-
lation of the internal size marker, PSMrel , is given by
PSMrel ¼
PSMav
Pmembrav
; (4)
where PSMav is the average internal marker population and P
membr
av is the
average membrane fluorophore population.
DCFBA assay
Liposomes were prepared as described by van den Bogaart (60). Briefly,
1,10-dioctadecyl-3,3,30,30-tetramethylindodicarbo-cyanine perchlorate (DiD;
Invitrogen, Carlsbad, CA) labeled-liposomes were prepared by rehydration
of a dried lipid film in the presence of glutathione (GSH)-labeled Alexa
Fluor 488 (AF488; Invitrogen) as a aqueous phase marker in buffer A.
The DiD/DOPG molar ratio was 1:12,000. Subsequently, the liposomes
were extruded 11 times through a 200-nm polycarbonate filter (AVESTIN,
Ottawa, Ontario, Canada). The liposomes were separated from the nonen-
capsulated fluorophores by centrifugation (20 min, 270,000  g, 20C)
and resuspended in buffer A to a final concentration of 5 mg/mL DOPG.
Fluorescence burst analysis was carried out on a laser-scanning confocal
microscope (62), as described by van den Bogaart (17,60,63). Different
amounts of peptide were added to 64 mg/mL DOPG liposomal solutions,FIGURE 1 The cyclic peptides cause large fluctuations in the membrane upo
simulation 9Ca. At 0 ns, all peptides were placed close to the bilayer and they
16 ns, when some lipids were pulled into the bilayer due to the action of the
peptides, one of which adopts a transmembrane orientation. The inner leaflet rela
as the starting structure (0 ns). An increase of the number of water molecules
(1–2 ns) and insertion of lipid headgroups further inside to form a toroidal-sha
lipid headgroups are depicted in large spheres. The peptide backbone is shown as
In the online figure, the cyclic peptide, BPC194, is always depicted in pink. To cla
and the glutamine residue are shown only for the peptide in a transmembrane orie
DOPG membranes. (D) I/V curves plotted from seven independent current trac
Biophysical Journal 100(10) 2422–2431yielding final peptide/lipid ratios from 1:52 to 5:1. The samples were equil-
ibrated for 10 min at room temperature after each addition of peptide. The
fluorescence bursts were measured for 10 min. To estimate the size of the
pore, a size marker was encapsulated inside the DiD-labeled vesicles,
i.e., 10 kDa dextran labeled with fluorescein (Invitrogen).RESULTS AND DISCUSSION
The cyclic peptide causes large perturbations
in DPPG bilayers
Simulations were performed with BPC194 interacting with
a DPPG bilayer at a P/L of 9:128. Phosphatidylglycerol
bilayers were chosen because the peptide is antimicrobial
(characterized by anionic lipids) with low hemolytic activity
(characterized by zwitterionic lipids). Previous results
indicated that BPC194 was the most active in 100% PG
membranes (64). The time course of a particular simulation
(see Table S1, 9Ca) is depicted in Fig. 1 A, but similar
behavior was observed in the remaining simulations (see
Table S1, 9Cb–9Cg). The peptides were initially placed in
the water layer close to the bilayer (0 ns) and subsequentlyn binding and can form a disordered toroidal pore. (A) Time course of the
bound within 5 ns. The first perturbation of the inner leaflet was seen at
cyclic peptide. The highest perturbation was at 109 ns and involved three
xed at 115 ns. (B) The snapshot of the transition state (A, 109 ns) was taken
inserting into the bilayer was followed by the opening of a water channel
ped pore (10–25 ns). A stable toroidal-shaped pore was seen at 65 ns. The
thick sticks, lipid tails as thin sticks, and water molecules as small spheres.
rify the bridging of the two leaflets in the transition state, the lysine residues
ntation. (C) Current traces recorded after the addition of BPC194 peptide to
e recordings of BPC194.
Action of Cyclic Antimicrobial Peptides 2425bound fast (~5 ns) to the membrane interface. During the
simulation, most of the peptides remained bound at the
interface, although a few peptides were able to coopera-
tively perturb the outer leaflet and consequently insert
deeper (Fig. 1 A, 16–60 ns).
In the perturbed state, the positively-charged residues of
the peptides interacted with the closest headgroup moieties
and pulled them, together with some water molecules, into
the core of the membrane. The peptide-free inner leaflet
was also affected by the action of the cyclic peptide bound
on the outer leaflet. This behavior was seen repetitively
during the simulation and was usually followed by a relaxa-
tion of both leaflets. Occasionally, a much larger perturba-
tion occurred (109 ns), characterized by a decrease in the
local lipid-chain order (see Fig. S1 A). At this point, the
perturbation was caused by a cooperative effect of three
peptides, one of which adopted a transmembrane-orienta-
tion with its glutamine residue close to the center of the
hydrophobic core. In this position, the glutamine residue
interacted with some headgroup atoms of the inner leaflet.
During this perturbation, a few water molecules were able
to cross the membrane. However, the inner leaflet relaxed
again and the orientation of the glutamine residue reverted
back to the interface (Fig. 1 A, 115 ns). Only smaller pertur-
bations of the membrane were observed in the remainder of
the simulation.The cyclic peptide can form a disordered
toroidal pore
In our previous simulations of AMP action (25,26), the first
event during pore formation was the bridging of the two
leaflets by a peptide. Although such an orientation of the
peptides was seen in simulation 9Ca (Fig. 1 A, 109 ns), it
did not lead to a porated state. Nevertheless, we expect
this highly perturbed state to be an intermediate, mimicking
the transition state toward pore formation. To sample the
conformational space around this so-called transition state,
10 simulations were set up. The velocities in the system
were varied to provide a different direction on the potential
energy surface that may lead to pore formation. Indeed,
a pore was formed in six out of ten simulations (for details,
see Table S2, C1–C10). The mechanism of the pore forma-
tion is depicted in Fig. 1 B, using C9 as a representative of
all simulations. The first time point (0 ns) was taken as the
transition state from which the simulation was started
(compare to Fig. 1 A, 109 ns).
Water molecules readily inserted into the bilayer and
finally after 1~2 ns, some water molecules crossed the
bilayer to open a water channel. Headgroup atoms of both
leaflets moved inside the membrane core to line the water
channel. From then on, the pore remained open and the lipid
headgroups of both leaflets rearranged to form a disordered
toroidal-shaped pore at ~25 ns. The size of the water channel
fluctuated in time as well as along the direction of the poreaxis, ranging between ~1 and 2 nm (see Fig. 1 B, 65 ns and
Fig. S1, B and C). The pores formed in our simulations
could be characterized as disordered toroidal pores with
the peptides residing in different positions and orientations.
In all cases, the pore was stabilized by three peptides—
a dimer and a monomer—with the remaining peptides lying
close to the pore. No peptide translocation was seen in the
nanosecond time regime of the simulations.Electrophysiology revealed that pore formation
is specific for cyclic peptides
To monitor the pore formation of BPC194, ion fluxes in
a planar lipid bilayer setup were measured. An example of
a current trace recorded upon addition of BPC194 to the
cis compartment of the planar lipid bilayer setup is shown
in Fig. 1 C. A voltage-dependent conductance was observed
implying that a pore or channel was formed/opened. These
conductance events were stable during the course of the
recording, pointing toward the formation of discrete pores.
The average I/V curve of all independent recordings is
plotted in Fig. 1 D.
Because the I/V curve is symmetric, the pores formed by
BPC194 are not ion-selective. All independent recordings
showed similar unitary pore conductance with an average
value of 0.61 5 0.12 nS. The diameter of the pore was
estimated (see Eq. 1) to range between 1.5 and 1.9 nm. At
higher peptide concentrations, we also observed higher
overall conductance that was a multiple of the unitary
conductance, reflecting the higher probability of pore forma-
tion. The same increase in probability of pore formation
was observed on applying voltages higher than 550 mV.
However, these extra poration events were transient with
shorter dwell times.The linear peptide does not perturb or porate
DPPG bilayers substantially
Simulations of the linear analog interacting with DPPG bila-
yers were performed under conditions identical to the cyclic
peptide (see Table S1, 9La–9Lf). A typical time course of
the simulation is depicted in Fig. 2 A. Upon binding, the
linear peptides somewhat perturb the membrane, albeit
much less than the cyclic ones. Larger perturbations leading
to a transition state were not seen in any of the simulations
with the linear peptide. Although the average thickness of
the bilayer is similar for the two peptides (3.7 5 0.1 nm
for the linear and 3.6 5 0.1 nm for the cyclic peptide),
the perturbations in the outer leaflet are substantially higher
when the cyclic peptide is attached. The fluctuations in
the outer leaflet, calculated as the deviation of the phos-
phorus atoms of the headgroups from their center of mass,
are 50.44 nm for the cyclic peptide in comparison
to50.29 nm for the linear peptide. These results were sup-
ported by the electrophysiology measurements, in which theBiophysical Journal 100(10) 2422–2431
FIGURE 3 Secondary structure related to the distance at the rim of the
pore and its function. (A) DSSP plot of the secondary structure of all
peptides for simulation C9, taking the transition state as the 0-ns time point.
(B) Top view of the pore showing the positions of the nine peptides. Region
1 peptides are those involved in the pore (within the inner concentric circle).
The peptides that remain at the rim of the pore (region 2) are delimited by
the outer concentric circle. The peptides furthest from the pore (region 3)
FIGURE 2 The linear peptides do not induce fluctuations in the
membrane. (A) Time course of the simulation L9a. Initially (0 ns), all linear
peptides were placed close to the outer leaflet. Within 10 ns, all peptides
bound and remained at the membrane interface. No large perturbations
were seen along the simulation (25–140 ns). The headgroups of DPPG
are depicted as large spheres, the peptide backbone as thick sticks, and lipid
tails as thin sticks. In the online figure, the linear peptide, BPC193, is
depicted in purple (B) Current traces recorded after the addition of
BPC193 peptide to DOPG membranes.
2426 Cirac et al.linear analog did not show pore formation or ion flux
through the membrane at the same voltage regime in which
the cyclic peptide formed pores (Fig. 2 B).are outside the circles. The peptides that remain at the rim of the pore
(region 2) are delimited by the red dashed line. The peptides furthest
from the pore (region 3) are outside the circles. (C) Parallel arrangement
of lysine residues in the b-structure (D) An example of the aligned lysine
residues stabilizing the lipid curvature in the porated state (side-view of
the pore). (E) The average distance between lysine residues K1-K8 and
K2- K7 (plotted as a sum) for peptides in regions 1, 2, and 3. The timescale
to the left of the gray line refers to simulation 9Ca (before transition state
formation 0–109 ns). The time frame to the right is an average for all simu-
lations (C1–C10) where a pore was formed with the starting time 0-ns being
the putative transition state.Structure-function relationship of the cyclic
peptide
To investigate the relation between secondary structure and
the ability of the peptides to stabilize a pore, we clustered
the peptides depending on how far they lie from the pore
and the role they play in stabilizing it (Fig. 3, A and B).
Three classes of peptides were distinguished: those within
the rim of the pore (distance 0.3 nm from the center of
the pore, region 1), those lying at the mouth of the pore
(within 0.3–1.5 nm, region 2), and those not involved in
the pore (further away than 1.5 nm, region 3) (Table 1).
Peptides in region 1 adopt a stable secondary structure
(40% b-structure) in all simulations where a pore is formed
(six simulations).
Although the number of residues involved in secondary
structure varied among the three peptides, all three showed
the longest persistence of b-structure over time (97%). The
peptides belonging to region 2 also exhibited a high b-struc-
ture (39% for peptides of this region), but the percentageBiophysical Journal 100(10) 2422–2431fluctuated over time and the persistence of b-structure was
89%. Finally, the peptides in region 3 exhibited multiple
folds and adopted different conformations showing only
18% b-structure for the individual peptides.
The apparent importance of the b-structure for stabiliza-
tion of the pore can be rationalized by considering the rela-
tive orientation of the lysine residues. As illustrated in Fig. 3
C, the b-structure gives rise to a parallel arrangement of the
lysine pairs (K1-K8 and K2-K7) on the two strands that,
presumably, facilitates the interaction of the lysines with
the lipid headgroups in the curved geometry of the pore
TABLE 1 Secondary structure and distance from the center of the pore for the peptides belonging to the three regions
Region Peptide Distance (nm) % Coil % b-structure % Bend % Turn % Time of b-structure
1 5 0.095 0 20.7 45.7 10.3 23.4 94.8
7 0.095 0 19.6 47.9 8.4 24.1 98.4
9 0.095 0 25.2 26.2 45.4 3.4 97.7
Average 0.095 0 22 5 1 405 6 315 11 175 6 97 5 1
2 2 0.305 0.05 29.9 43.8 2.8 23.6 92
3 0.785 0.15 24.8 42.8 12.0 20.4 92.6
6 1.105 0.15 36.0 32.2 14.2 16.5 91.7
8 1.505 0.23 30.0 39.1 10.9 20.0 78.1
Average 0.95 0.2 30 5 2 395 2 105 2 205 1 89 5 3
3 4 1.595 0.30 38.5 28.1 15.3 18.2 62.5
1 2.075 0.25 45.4 8.6 30.9 15.1 33.6
Average 1.85 0.2 42 5 2 185 7 235 6 175 1 48 5 10
The values reported are an average calculated from all simulations where a pore was formed. The center of the pore is defined as the center of mass of the
three region 1 peptides that form the pore (backbone only). The time of persistence of b-structure (see Materials and Methods) is also reported. The standard
errors reported are calculated from the standard deviation, between all peptides in all simulations.
Action of Cyclic Antimicrobial Peptides 2427(Fig. 3D). The distances between the lysine pairs K1-K8 and
K2-K7 (plotted as a sum of the two values) for the three
regions of the peptides is shown in Fig. 3 E. When the
peptides are bound to the membrane (0–109 ns, until gray
line), the value fluctuates for all three clusters of peptides.
However, once the transition state is reached and later
when a pore is opened (beyond gray line), the distance
between the lysine pairs in the peptides in region 1 remained
low, consistent with their high persistence of secondary
structure. The value for the peptides in region 2 was also
low at the transition state but increases as the pore relaxes.
The peptides in region 3, which were not involved in the
pore, showed the largest distance between the lysine pairs
along the simulations.FIGURE 4 The linear peptides cause large perturbations from the
in silico modified transition state. Time course of a transient pore formed
by a linear peptide (simulation L7). The time point 0-ns corresponds to
the transition state taken from the simulation with the cyclic peptide. After
10–30 ns, large perturbations were seen and a few water molecules crossed
the bilayer. Please note that in most simulations, the bilayer relaxes and
such large perturbations are not seen.Transition state alchemy: why the linear peptide
cannot stabilize pores
To test whether the b-strand conformation is indeed linked
to activity, we repeated the simulations from the transition
state with the linear peptide by in silico alchemy, i.e.,
removing the peptide bond between the first and last residue.
The results of these simulations are summarized in Table S2
(L1–L10). In seven of the ten simulations, the bilayer
relaxed and the linear peptide moved back to the interface.
In the remaining three simulations, a water channel eventu-
ally opened. The time course of one of the poration events
(L7) is depicted in Fig. 4. Although we observed that the
linear peptide is also able to stabilize a water pore (starting
from the perturbations caused by the cyclic peptide), the
pore differs from the pore formed in the presence of the
cyclic peptides:
1. Only one of the three peptides involved in the transition
state remained embedded near the central pore region;
and
2. The lipid headgroups did not line the pore as clearly as
in the case of the cyclic peptide. In most of the simula-
tions, the average percentage of b-structure dropped toa value at ~20%, compared to >30% for the cyclic
peptide (compare to Table S2, C1–C10).
In the simulations in which a pore was formed, the
peptide nearest the pore preserved a somewhat higher
percentage of b-structure (~28%). Two additional unbiased
transition state simulations of the linear peptide in its native
random-coil conformation were performed. We found that,
in the extended conformation, the peptide could not stabilize
even those headgroups that were already inserted into the
membrane, and the bilayer recovered immediately from
the large perturbations induced by the cyclic peptide. An
overview of the poration features of the cyclic and linear
peptide is presented in Table 2.DCFBA reveals the mechanism of action
on liposomes
Fig. 5 shows the result of DCFBA experiments carried out
with BPC194 and BPC193 in the presence of DiD-labeled
DOPG vesicles filled with the internal marker, GSH-
AF488. In such an experiment, poration of liposomes
reduces the internal marker concentration and the DCFBA
population histogram shifts to lower concentration values.Biophysical Journal 100(10) 2422–2431
TABLE 2 Summary of pore features created by the cyclic
peptide and the linear peptide
Pore features Cyclic peptide Linear peptide
Pore propensity High Low
Pore diameter 1–2 nm <1 nm
Number of peptides inside 3 1
% b-structure 34% 21%
Outer leaflet deviation 50.55 50.48
Number of porated states 6/10 3/10
Number of lipid headgroups 8–11 6–10
Number of water molecules 100–123 76–84
Formation time 1–4 ns 3–30 ns
2428 Cirac et al.In contrast, membrane fusion or aggregation results in
a decrease in the number of detected liposomes, which is
observed as a decrease in the area of the population histo-
gram. For the cyclic analog, at low P/L ratios (%1), theBiophysical Journal 100(10) 2422–2431number of liposomes decreased, which is indicative of
fusion or aggregation (Fig. 5 A).
The membrane fusion/aggregation activity was confirmed
by confocal imaging of the liposomes and was accompanied
by leakage of the internal marker (Fig. 5 A and B, P/L of
0.3). Intriguingly, by adding an excess of peptide (P/L of
1–5) such that the vesicles are completely shielded by
peptide preventing aggregation/fusion, the number of
detected liposomes was restored and the concentration of
molecules inside the liposomes dropped (Fig. 5 A, panel
g), which is indicative of pore formation. The linear peptide,
BPC193, also caused membrane fusion or aggregation
but at higher P/L than its cyclic counterpart (Fig. 5 B).
This was confirmed by confocal imaging at the highest
concentration of the linear peptide (P/L of 5) where large
membrane aggregates were formed without loss of theFIGURE 5 Mechanism of action of peptides
studied by DCFBA. (A and B) DCFBA population
histograms of BPC194 and BPC193, respectively.
Numbers in the subpanels refer to P/L ratios. The
y axis corresponds to the number of liposomes,
and the x axis to the arbitrary marker concentration
inside the liposomes. (Right panels) Confocal
images of vesicles probed in the experiments
shown in panels A and B, indicated by Greek
symbols (a-d). (Leftmost panels) Membrane probe,
DiD. (Rightmost panels) Internal marker probe,
GSH-AF488. The scale bar is 20 mm. (C and D)
Average DiD population (circles, solid line) and
relative GSH population (squares, dotted line) for
the cyclic and the linear peptide, respectively.
Action of Cyclic Antimicrobial Peptides 2429internal marker, indicative of the lack of pore formation
(Fig. 5 A, panel d).
To present the overall data comprehensively, the average
membrane fluorescence per liposome and the relative
concentration of the internal marker are plotted in Fig. 5,
C and D (see Materials and Methods for more details).
For BPC194, the average membrane fluorescence peaked
at a P/L ratio of 0.5–1, while the relative concentration of
the internal marker already dropped to zero at a P/L of
0.3. This behavior confirms the leaky fusion/aggregation
action of the cyclic peptide. On the other hand, for
BPC193, an increase in the membrane population and
constant relative internal marker population was seen,
thereby corroborating its nonleaky fusion/aggregation
propensity.
By using the DCFBA technique and encapsulating bigger
internal markers, we could estimate the size of the pore. The
smallest molecule that did not leak out was the 10 kDa
dextran-fluorescein (see Fig. S2 A) with a dimension of
2.1 nm (shortest axis measured assuming is a prolate ellip-
soid), whereas GSH-AF488 leaked out with a diameter of
~1.7 nm (see Fig. S2 B, measured by fluorescence correla-
tion spectroscopy). We conclude that the size of the pore
is between 1.7 and 2.1 nm.DISCUSSION
Nature of the transition state
The simulations presented here elucidate the nature of the
transition state of the poration process. One may assume
that starting from a true transition state, the chance of
arriving at either side of the transition state barrier is approx-
imately equal (here the porated membrane versus the intact
membrane). Although our statistics are necessarily limited,
we observe 6 out of 11 simulations with the cyclic peptide to
reach a porated state, starting from the state in which a large
perturbation was observed in the original simulation
(see Table S2, C1–C10). In the remaining 5 out of 11 simu-
lations, counting also the original trajectory, the system
relaxed back to the intact membrane state. This intermediate
or transition state is characterized by a single peptide
bridging the two leaflets (compare to Fig. 1 B, 0 ns). The
results are in line with kinetic models that suggest such
a state is important in pore formation (65).Disordered toroidal pore
Using the transition state as seen for many independent
trajectories, we were able to show that the deepest-
embedded peptides may stabilize a toroidal-shaped pore of
1–2 nm diameter, which is in line with the electrophysiology
and pore-sizing DCFBA experiments carried out indepen-
dently. Only two/three peptides actually lie in the pore while
some of the remaining peptides line the mouth of the poreand stabilize the membrane curvature. The structure of the
pore is reminiscent of pores seen in previous MD studies
(24–26,66) and has been termed the disordered toroidal
pore.Structure-function relationship
In this study, comparisons between a cyclic antimicrobial
peptide and its inactive linear analog have highlighted the
importance of b-structure for its activity, similar to that
seen for an antitumor cyclic peptide (67). For BPC194,
a constrained secondary structure rather than a high
percentage of secondary structure was required to stabilize
the pore. The importance of the secondary structure,
induced on membrane binding and stabilized in the porated
state, appears to be the alignment of the charged residues
such that they fit the toroidal shape of the pore (compare
to Fig. 3 D). This explains why the linear peptide is less
active—for entropic reasons a folded structure is less favor-
able. This entropic penalty is prepaid by the cyclic peptide.
Thus, the linear peptide cannot open a pore but may stabilize
it, if the starting structure is the transition state structure
obtained with the cyclic peptide (see Fig. 4).Conductance, pore properties,
and fusion/aggregation
BPC194 forms stable and nonselective ion pores in planar
lipid bilayer experiments, with a unitary conductance of
0.61 5 0.12 nS, corresponding to a pore diameter of
1.5–1.9 nm. This is in contrast to other cyclic peptides
such as gramicidin S that do not form stable pores (68).
Stable pores have, however, been seen for linear antimicro-
bial peptides such as alamethicin, magainins, and defensins
(69). Both the cyclic and linear peptides are fusogenic or
cause aggregation, as indicated by DCFBA measurements,
but only the cyclic peptide caused leakage as well. Similar
to melittin (61), BPC194 causes leakage at the same concen-
tration regime at which it fuses or aggregates DOPG
membranes. However, further studies in this intriguing
fusion/aggregation action are in progress.CONCLUSIONS
There is now compelling evidence that cyclization of certain
sequences of membrane-active peptides enhances their anti-
microbial performance. In this article, we analyze the
molecular basis for the differences in activity of analogous
cyclic and linear antimicrobial peptides. We show that the
molecular basis for the enhanced activity resides most likely
in the restriction of the number of conformations in the
cyclic peptide. We show that it can adopt a favorable orien-
tation toward the membrane and acquire an ordered struc-
ture that allows a high charge density and amphipathic
arrangement.Biophysical Journal 100(10) 2422–2431
2430 Cirac et al.The latter allows the cyclic peptide to perturb the
membrane substantially and to form discrete pores. Cycliza-
tion of the linear sequence locks the peptide in a poration-
ready state, allowing it to perturb the bilayer and stabilize
the curvature of a toroidal transmembrane pore. Without
cyclization, entropy destabilizes the formation of a folded
structure and consequently its amphipathic-like character,
and hence the linear peptide has a much lower propensity
to induce pores. The work presented here provides detailed
insight into the mode of action of cyclic peptides and will
aid rational design of new antimicrobial molecules.SUPPORTING MATERIAL
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